Kinesin family member 14 expression and its clinical implications in colorectal cancer

doi:10.4251/wjgo.v17.i3.102696

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (159)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-12) series.

Item

Count

PDF

HTML

Figures (1-12)

Sum=127

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=26

Mar 15, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Mar 15, 2025; 17(3): 102696
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102696

Full Size Figure Download Figure

Figure 7 Detailed evaluation of Kinesin family member 14 expression levels in colorectal cancer. A: Summary receiver operating characteristic curve; B: Sensitivity and specificity; C: Positive diagnostic likelihood ratio (DLR) and negative DLR. DLR: Diagnostic likelihood ratio; sROC: Summary receiver operating characteristic; AUC: Area under the curve.

Citation: Qin K, Luo JY, Zeng DT, Huang WY, Li B, Li Q, Zhan YT, He RQ, Huang WJ, Chen G, Chen ZY, Chi BT, Tang YX, Tang RX, Li H. Kinesin family member 14 expression and its clinical implications in colorectal cancer. World J Gastrointest Oncol 2025; 17(3): 102696
URL: https://www.wjgnet.com/1948-5204/full/v17/i3/102696.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i3.102696